公开(公告)号：US20220135694A1

公开(公告)日：2022-05-05

申请号：US17427291

申请日：2020-01-30

Applicant: LAVA THERAPEUTICS B.V.

Inventor： Johannes Jelle VAN DER VLIET ,  Iris DE WEERDT ,  Tanja Denise DE GRUIJL ,  Paul PARREN ,  Aron Philip KATER ,  George Lodewijk SCHEFFER

IPC: C07K16/28 ,  A61P35/00

Abstract: The present invention relates to novel antibodies capable of binding human CD40 and to novel multispecific antibodies capable of binding human CD40 and capable of binding a human Vγ9Vδ2 T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.